Grant: Discovery Grants Program - Individual
Simon Fraser University
$63,000.00
Molecular switching in materials and health science applications
EF 2007-08
Résumé
Research in the Branda group revolves around a central theme - the relationship between structure and function and how, if one can reversibly alter a molecule's structure, one can also control its behaviour in molecule-based devices. The group has made tremendous progress, preparing and studying a wide range of photo- and electroresponsive compounds possessing "made-to-order" properties that can be both tuned and modulated. Efforts are now aimed at integrating these "molecular switches" into important applications. A major focus of our research program will be on developing new photodynamic therapy (PDT) strategies for releasing known therapeutics on command. An alternative to the costly process of discovering new drugs is to improve the effectiveness of existing therapeutics or experimental drugs through novel delivery methods that target only diseased cells. Provided that photoactivated drugs are non-toxic in the dark, PDT can activate a drug at a chosen location by using light triggers, minimizing systemic toxicity. We are developing unprecedented approaches for PDT using photoswitches and are working closely with researchers at Vancouver General Hospital's Prostate Centre to evaluate the effectiveness of our strategies in targeting prostate cancer cells and in autoimmune diseases such as psoriasis (a T-cell mediated skin disorder), atopic dermatitis (eczema), rheumatoid arthritis and nephritic syndrome. Another project aims to develop photoswitches that can act as photodynamic reagents and catalysts and influence the outcome of chemical reactions. This is a relatively unexplored area that can make a tremendous impact on chemical synthesis, catalysis, drug delivery and sensing. Additional research aims to use photoswitches to "lock and release" thermal polymerization reactions, and to develop photoresponsive cyclophanes for selective host-guest complexation.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
194262-2006
Name nom
Branda, Neil
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
63000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
2
Nb partie
5
Application title
Molecular switching in materials and health science applications
Keyword
NA
Application summary
Research in the Branda group revolves around a central theme - the relationship between structure and function and how, if one can reversibly alter a molecule's structure, one can also control its behaviour in molecule-based devices. The group has made tremendous progress, preparing and studying a wide range of photo- and electroresponsive compounds possessing "made-to-order" properties that can be both tuned and modulated. Efforts are now aimed at integrating these "molecular switches" into important applications. A major focus of our research program will be on developing new photodynamic therapy (PDT) strategies for releasing known therapeutics on command. An alternative to the costly process of discovering new drugs is to improve the effectiveness of existing therapeutics or experimental drugs through novel delivery methods that target only diseased cells. Provided that photoactivated drugs are non-toxic in the dark, PDT can activate a drug at a chosen location by using light triggers, minimizing systemic toxicity. We are developing unprecedented approaches for PDT using photoswitches and are working closely with researchers at Vancouver General Hospital's Prostate Centre to evaluate the effectiveness of our strategies in targeting prostate cancer cells and in autoimmune diseases such as psoriasis (a T-cell mediated skin disorder), atopic dermatitis (eczema), rheumatoid arthritis and nephritic syndrome. Another project aims to develop photoswitches that can act as photodynamic reagents and catalysts and influence the outcome of chemical reactions. This is a relatively unexplored area that can make a tremendous impact on chemical synthesis, catalysis, drug delivery and sensing. Additional research aims to use photoswitches to "lock and release" thermal polymerization reactions, and to develop photoresponsive cyclophanes for selective host-guest complexation.